For Media

The media's connection to global experts in medicine, science, nursing and public health.

The Office of News & Communications connects print, broadcast and online media interested in learning more about research, education, and patient care to experts at Vanderbilt University Medical Center.

Interested in a phone, email or in-person interview? Call (615) 322-4747.
All media are required to be escorted by a member of our department when visiting facilities and patient care areas.

News Releases

Recent press releases approved for use by print, broadcast or online media.

Vanderbilt contributes $22.13 billion to Tennessee, Nashville economies since 2019 

As the largest private employer in the Nashville area and the second-largest private employer in Tennessee, Vanderbilt’s reach extends far beyond its campus to shape the region’s economy, quality of life and future growth.

C. diff uses toxic compound to fuel growth advantage

The findings of a new research study increase understanding of the molecular drivers of C. diff infection and point to novel therapeutic strategies aimed at a pathogen that causes about half a million infections in the U.S. each year.

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

The milestone creates one of the largest, most comprehensive clinical genomic datasets of its kind; multiomic data to be added in next phase of program

Where are all the Alzheimer’s drugs?

A new study will use innovative methods developed at VUMC to look for drugs already approved for other uses that could potentially be repurposed to treat Alzheimer’s.

Lis Henley, MSN, RN, APRN, FNP-BC, EMT

Lis Henley wins L. Gale Allen President’s Leadership Award at Mid-Winter Conference for Tennessee Ambulance Service Association

The award is presented to an individual who provides exemplary service and support to emergency medical services in Tennessee.

VUMC to develop AI technology for therapeutic antibody discovery

The approach will address “bottlenecks” that slow the traditional antibody discovery process, and it aims to make it possible to generate monoclonal antibody therapies against any target of interest.